In gene therapy manufacturing, viral vectors have long been the primary method for gene modification. However, recent innovations, combined with the evolving demands of the genetic medicines market, are driving…
Read More
Tag
Executive Summary
Do you need support or have questions?
Find out how our cell-free DNA technology could accelerate your genetic medicine projects.
- Industry-leading expertise in enzymatic DNA production.
- Custom solutions tailored to your specific research needs.
- Scalable, high-purity DNA to support innovative therapies.
- Let’s drive innovation in genetic medicine with enzymatic DNA technology together.
Get the latest Touchlight news, trends and innovative solutions in genetic medicine.
Sign up for our newsletter, Cell-Free Insights
Touchlight pioneers scalable, cell-free DNA technology, transforming gene therapy and genetic medicine. With a commitment to innovation, excellence, and a diverse team, we push boundaries to deliver safer, more efficient solutions for the future.
© 2026 Touchlight Privacy Policy / Cookie Policy / Policies & Statements / Terms of Use / Suppliers / Biosecurity Commitment